Innovations in Platform Technologies: New Modalities and Drug Delivery Systems

Takeda Pharmaceutical are launching an open innovation initiative, inviting researchers to submit their ideas and technologies across five different focus areas, up to £85k / €100k / $150k (AUD). Summarised below are the interests of Takeda relating to innovations in platform technologies focused on new modalities and drug delivery systems. In the attached application form, each of these subtopics have been expanded upon to give further detail of proposals that would be within scope. 

Submissions should be relevant to one or more of the following titles: 

• REF#25: Chemistry-driven novel methods or ideas to bring breakthrough into Central Nervous System (CNS) drug discovery
• REF#26: Chemistry-driven novel technologies, methods, or ideas to solve issues in drug discovery with new modalities
• REF#27: Chemistry-driven novel technologies, methods, or ideas to improve and/or accelerate the drug discovery process
• REF#28: Research on novel technologies and ideas in targeted protein degradation for drug discovery
• REF#29: Novel analysis methods and ideas associated with drug discovery based on human genetics
• REF#30: Novel analysis methods and ideas for exploring prediction markers of disease-subpopulation based on human big data
• REF#31: Research on novel technologies and ideas of drug discovery targeting nucleic acids
• REF#32: Development of efficient drug delivery technologies to skeletal and cardiac muscles

Jurisdictions of Interest

Only submissions from Europe and Australia will be eligible for this campaign.

Submission Information

To view more details on each area of interest seeking proposals for funding, download an application form here. For an FAQ covering subjects like funding and IP terms, click here. To submit your proposal, please visit discover.in-part.com, register, and submit as a Research Project under the appropriate Discover campaign.